ARVO/Alcon Keynote Series

Opening Keynote Session
Components, Computation, Cognition: The Allen Institute for Brain Science 2020 Vision

Allan Jones, PhD, CEO, Allen Institute for Brain Science, Seattle, Wash. 

The Allen Institute for Brain Science is a non-profit research organization dedicated to providing tools and data for the larger research community. Launched in 2003, the Allen Institute has created a suite of large-scale data efforts along with a web portal to view and analyze the data. These efforts include gene expression atlases of the developing and adult mouse brain and spinal cord, developing and adult human and non-human primate gene expression studies and connectivity atlases of the mouse brain. In 2012, the Allen Institute launched an ambitious $1 billion, 10-year program to systematically characterize the structure and function of the circuitry of the mouse visual system, along with characterization of cell types in the human brain. The presentation will cover an overview of the Allen Institute, its current projects and infrastructure, a few data highlights and a look at future directions.

Closing Keynote Session
Panel Discussion -- Human Genetics in Vision and Ophthalmology

 Anneke den Hollander, PhD  

Janey Wiggs, MD, PhD, FARVO

The accessibility of the eye for structural and functional phenotype analysis provides exceptional opportunities to advance human genetics and use modern sequencing of thousands of patients for a new understanding of the genetics of vision. This session will discuss some of the most sophisticated genetic technologies available and provide insight into novel approaches to vision genetics.

ARVO TBI Session

Vision and Traumatic Brain Injury: The Outlook for Therapeutics

Researchers are learning more about the significance of visual function in the evaluation of traumatic brain injury (TBI). During this interactive session, vision scientists and neuropathologists will discuss the impact of systematic, early assessment¬ of the visual system on the potential for therapeutic protection and intervention against TBI. The program provides opportunities for interactions between attendees, panelists and patients.

ARVO/Champalimaud Award Lecture

Generating evidence to inform practices, programmes, and policies on what works to reduce vision loss in sub-Saharan Africa

The Antonio Champalimaud Vision Award, established by the Champalimaud Foundation in 2006, honors outstanding contributions to the preservation and understanding of sight.

Outbreaks: The global ophthalmic threat of Ebola, Zika and other viruses

Recent outbreaks of viruses such as Ebola, Zika and West Nile have reminded the ophthalmology community that emerging systemic infectious diseases may lead to sight-threatening consequences. This session focuses on these threats, specifically emphasizing the importance of ophthalmologists and vision researchers in contributing to an understanding of disease mechanism and treatment as well as the urgent need for improved ophthalmic screening and care. Speakers will provide scientific, clinical and humanitarian perspectives and highlight current understanding of these eye diseases and the importance of strengthening vision health systems globally.


Latest advances in eye and vision research from the ARVO 2016 Annual Meeting

Major funders of eye and vision research being presented at the ARVO Annual Meeting:

  • Paul Sieving, MD, PhD, FARVO, Director, National Eye Institute
  • Brian Hofland, PhD, President, Research to Prevent Blindness
  • Stephen Rose, PhD, Chief Science Officer, Foundation Fighting Blindness
  • Robert Read, Manager, Department of Defense Vision Research Program (part of the Congressionally Directed Medical Research Programs)